Cardiopaties congènites: un futuro previsible

Jaume Casaldàliga, Jaume.
Pediatr. catalan ; 63(2): 53-55, mar.-abr. 2003.
Artículo en Español | IBECS (España) | ID: ibc-142064

Documentos relacionados

  1. Recent Advances on Selenium Nutrition and Keshan Disease.
  2. The Evolving Paradigm of Revascularization in Ischemic Cardiomyopathy: from Recovery of Systolic Function to Protection Against Future Ischemic Events.
  3. Dual integrin αvß3 and αvß5 blockade attenuates cardiac dysfunction by reducing fibrosis in a rat model of doxorubicin-induced cardiomyopathy.
  4. The protective effect of the mitochondrial-derived peptide MOTS-c on LPS-induced septic cardiomyopathy.
  5. Angiotensin-(1-9) attenuates adriamycin-induced cardiomyopathy in rats via the angiotensin type 2 receptor.
  6. Arrhythmia in Cardiomyopathy: Sex and Gender Differences.
  7. Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
  8. Selenium Deficiency as a Risk Factor for Peripartum Cardiomyopathy.
  9. [Cardiomyopathies: a practical approach to the assessment and management of patients and their families].
  10. [The prevalence of atrial cardiomyopathy in patients with different types of acute ischemic stroke and its relationship with cryptogenic stroke].